Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 62

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 62
---
 to 2,868,168, rounded down to the nearest whole share, divided by the Kineta Fully Diluted Common Stock, rounded down to six (6) decimal places. |

| (5) | Assumes that a Kineta stockholder is record owner of ten (10) shares of Kineta Common Stock as of the Effective Time. Holders of Kineta Common Stock will only receive whole shares of TuHURA Common Stock and will receive cash in lieu of fractional shares of TuHURA Common Stock that would have otherwise been issued, all pursuant to the terms of the Merger Agreement. |

Treatment of Kineta Stock Options and Kineta Warrants (see page 228) At the Effective Time:

| • |     | each In-the-Money Company Stock Option that is vested or unvested and held by a Person will be entitled to exercise such In-the-Money Company Stock Option as set forth in the applicable Optionholder Treatment Agreement and, upon such exercise, will be entitled to receive the Merger Consideration; |

| • |     | each Out-of-the-Money Company Stock Option held by a Person will be canceled and extinguished for no consideration; |

| • |     | the Pre-2023 Company Warrants will terminate upon their terms if such Pre-2023 Company Warrants are not previously exercised (if the Pre-2023 Company Warrants are exercised prior to the Effective Time, as a holder of shares of Kineta Common Stock, the holder of such former Pre-2023 Company Warrants will be entitled to receive the Merger Consideration); |

| • |     | the 2023 Company Warrants will be entitled to the benefits as set forth in the applicable Warrantholder Treatment Agreement. |

**On March 7, 2025, Kineta entered into a securities exchange agreement (the “Exchange Agreement”) with an existing investor and holder of some of the 2023 Company Warrants (the “Holder”) pursuant to which Kineta agreed to issue an aggregate of 1,880,342 shares of Kineta Common Stock consisting of (i) an aggregate of 1,225,323 shares of Kineta Common Stock and (ii) a pre-funded warrant to purchase up to an aggregate of 655,019 shares of Kineta Common Stock, in exchange for certain outstanding 2023 Company Warrants (the “Prior Warrants”) held by the Holder to purchase up to 2,315,387 shares of Kineta Common Stock with exercise prices ranging from